Skip to main content
. 2010 Mar 25;115(24):4999–5004. doi: 10.1182/blood-2010-01-263012

Figure 4.

Figure 4

The TFS in children with enoxaparin prophylaxis compared with patients without prophylaxis is shown. Children with ALL without prophylaxis (▼) showed a significantly reduced TFS than children with prophylactic low-molecular-weight heparin (LMWH; ●).